Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device Tax Delay? 18 Senate Dems Say ‘Yes’; Obama Says ‘No’

This article was originally published in The Pink Sheet Daily

Executive Summary

Potential delay of the device tax seemed to gain momentum with a recent letter from 18 Senate Democrats to Senate Majority Leader Reid, but the president and Senate Finance Committee leadership are not on board.

You may also be interested in...



Device Firm Dollars Go To Senators Favoring Repeal Of Excise Tax

In the upcoming 2014 Senate election, medtech firms spending the most campaign dollars are backing Senators who would vote to repeal the device excise tax, Republican incumbents, and friends to the industry running tight races. Story and detailed data infographic on key races and campaign contributions.

Final IRS Device Tax Rule Changes Little From Draft As Industry Focuses On Repeal Effort

Though the IRS final regulation offers some wins for industry, manufacturers continue to seek repeal of the device tax.

Device Industry Amps Up Efforts To Repeal Device Tax In Lame Duck Session

Industry groups flew in more than 50 CEOs to visit Capitol Hill, launched an ad campaign and released an impact report last week as part of a stepped-up effort to get Congress to repeal the impending medical device tax before it goes into effect Jan. 1.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS073639

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel